| Erinn Denise Urquiaga, LCPC | |
|
688 N Beachwood St, Eagle, ID 83616-5046 | |
| (208) 420-7311 | |
| Not Available |
| Full Name | Erinn Denise Urquiaga |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 688 N Beachwood St, Eagle, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154595759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YS0200X | Counselor - School | LCPC-360 (Idaho) | Secondary |
| 101YM0800X | Counselor - Mental Health | LCPC-360 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erinn Denise Urquiaga, LCPC 688 N Beachwood St, Eagle, ID 83616-5046 Ph: (208) 420-7311 | Erinn Denise Urquiaga, LCPC 688 N Beachwood St, Eagle, ID 83616-5046 Ph: (208) 420-7311 |
News Archive
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.
While the nucleus of a cell may be its command headquarters, mitochondria are equally vital—they are the power plants of the cell, and without them all cellular activity would quickly and irrevocably come to a halt.
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
Julie Lopez, 21, has been tested regularly for sexually transmitted diseases since she was a teenager. But when Lopez first asked her primary care doctor about screening, he reacted with surprise, she said.
› Verified 8 days ago
Ms. Carol Tidwell, MS. LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 225 S Linder Rd Apt A308, Eagle, ID 83616 Phone: 208-546-1808 | |
Kenzington Price, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1159 E Iron Eagle Dr Ste 100, Eagle, ID 83616 Phone: 208-938-2836 Fax: 208-938-2897 | |
Angela Brewster, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 380 W State St, Eagle, ID 83616 Phone: 406-570-4698 | |
Mrs. Megan Irene Osborne, PH.D, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 764 E. Ashbourne Ln., Eagle, ID 83616 Phone: 208-734-0022 Fax: 208-734-0855 | |
Dr. Logan Marsh Lamprecht, PH.D., LCPC, M. COUN Counselor Medicare: Not Enrolled in Medicare Practice Location: 533 E Riverside Dr # 120533e, Eagle, ID 83616 Phone: 208-339-1279 | |
Megan Koehler, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 S Fitness Pl Ste 110, Eagle, ID 83616 Phone: 208-861-5279 | |
Jacob Gary Dyer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1197 S River Flow Way, Eagle, ID 83616 Phone: 208-921-0796 |